LOPW
ABBV icon

Live Oak Private Wealth’s AbbVie ABBV Stock Holding History

Live Oak Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Sell
17,541
-336
-2% -$72.3K 0.55% 60
2026
Q1 		$3.89M Sell
17,877
-208
-1% -$46.1K 0.54% 57
2025
Q4 		$4.13M Sell
18,085
-70
-0.4% -$15.9K 0.56% 53
2025
Q3 		$4.2M Hold
18,155
– – 0.59% 55
2025
Q2 		$3.37M Buy
18,155
+310
+2% +$57.6K 0.5% 59
2025
Q1 		$3.74M Buy
17,845
+50
+0.3% +$9.72K 0.61% 54
2024
Q4 		$3.16M Sell
17,795
-639
-3% -$117K 0.53% 55
2024
Q3 		$3.64M Sell
18,434
-936
-5% -$175K 0.59% 56
2024
Q2 		$3.32M Sell
19,370
-327
-2% -$54.2K 0.57% 58
2024
Q1 		$3.59M Buy
19,697
+5
+0% +$862 0.62% 56
2023
Q4 		$3.05M Sell
19,692
-248
-1% -$36.2K 0.57% 53
2023
Q3 		$2.97M Sell
19,940
-232
-1% -$34.1K 0.63% 49
2023
Q2 		$2.72M Sell
20,172
-19
-0.1% -$2.79K 0.54% 53
2023
Q1 		$3.22M Sell
20,191
-467
-2% -$71.4K 0.67% 50
2022
Q4 		$3.34M Sell
20,658
-325
-2% -$49.8K 0.69% 49
2022
Q3 		$2.82M Buy
20,983
+766
+4% +$110K 0.63% 57
2022
Q2 		$3.1M Buy
20,217
+1,748
+9% +$267K 0.65% 59
2022
Q1 		$2.99M Sell
18,469
-2,000
-10% -$291K 0.58% 60
2021
Q4 		$2.77M Sell
20,469
-110
-0.5% -$13K 0.52% 59
2021
Q3 		$2.22M Buy
20,579
+2,829
+16% +$323K 0.45% 60
2021
Q2 		$2M Buy
17,750
+38
+0.2% +$4.28K 0.44% 59
2021
Q1 		$1.92M Sell
17,712
-163
-0.9% -$17.4K 0.47% 58
2020
Q4 		$1.92M Buy
17,875
+2,020
+13% +$194K 0.54% 56
2020
Q3 		$1.39M Sell
15,855
-76
-0.5% -$7.16K 0.48% 58
2020
Q2 		$1.56M Buy
+15,931
New +$1.4M 0.57% 57

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Live Oak Private Wealth's ABBV Position: Q2 2026 in Review

Live Oak Private Wealth reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $72.3K and leaving 17,541 shares worth $4.41M. The position accounts for 0.55% of the portfolio, ranked #60.

Live Oak Private Wealth first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Live Oak Private Wealth held 17,541 shares of AbbVie worth $4.41M as of Q2 2026.
  • Live Oak Private Wealth sold 336 AbbVie shares in Q2 2026, an estimated $72.3K.
  • AbbVie made up 0.55% of Live Oak Private Wealth's portfolio in Q2 2026, its #60 holding.
  • Live Oak Private Wealth first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Live Oak Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.